Difference between revisions of "IolG"
Line 83: | Line 83: | ||
=== Database entries === | === Database entries === | ||
− | * '''Structure:''' {{PubMed|20809899}} | + | * '''Structure:''' [http://www.rcsb.org/pdb/explore/explore.do?structureId=3MZ0 3MZ0] {{PubMed|20809899}} |
* '''UniProt:''' [http://www.uniprot.org/uniprot/P26935 P26935] | * '''UniProt:''' [http://www.uniprot.org/uniprot/P26935 P26935] | ||
Line 132: | Line 132: | ||
=References= | =References= | ||
− | <pubmed>9226270,6322857,1761221,112095,,9887260,18310071 112095 | + | <pubmed>9226270,6322857,1761221,112095,,9887260,18310071 112095 </pubmed> |
− | + | '''Additional publications:''' {{PubMed|20809899}} | |
[[Category:Protein-coding genes]] | [[Category:Protein-coding genes]] |
Revision as of 18:10, 6 December 2010
- Description: inositol 2-dehydrogenase
Gene name | iolG |
Synonyms | idh, iol |
Essential | no |
Product | inositol 2-dehydrogenase |
Function | myo-inositol catabolism |
Metabolic function and regulation of this protein in SubtiPathways: Sugar catabolism | |
MW, pI | 38 kDa, 4.865 |
Gene length, protein length | 1032 bp, 344 aa |
Immediate neighbours | iolH, iolF |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
The gene
Basic information
- Locus tag: BSU39700
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
Categories containing this gene/protein
utilization of specific carbon sources
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: Myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH (according to Swiss-Prot)
- Protein family: gfo/idh/mocA family (according to Swiss-Prot)
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s): NAD(+) PubMed
- Effectors of protein activity:
- Interactions: the protein forms a tetramer PubMed
- Localization:
Database entries
- UniProt: P26935
- KEGG entry: [3]
- E.C. number: 1.1.1.18
Additional information
Expression and regulation
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody:
Labs working on this gene/protein
- Yasutaro Fujita, University of Fukuyama, Japan
- Ken-ichi Yoshida, Kobe University, Japan
Your additional remarks
References
Additional publications: PubMed